Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Condition:   HER2-positive Breast Cancer Interventions:   Other: RNA sequencing;   Other: Transcriptome analysis;   Drug: Trastuzumab;   Drug: Chemotherapy Sponsors:   Omicsway Corporation;   Oncobox Ltd., Russia;   Vitamed, Russia;   Republican Oncological Dispensary of Karelia Republic, Russia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials